Shotgun proteomics for the characterization of subunit composition of mitochondrial complex I  by Pocsfalvi, Gabriella et al.
1757 (2006) 1438–1450
www.elsevier.com/locate/bbabioBiochimica et Biophysica ActaShotgun proteomics for the characterization of subunit
composition of mitochondrial complex I
Gabriella Pocsfalvi a,⁎, Manuela Cuccurullo a, Gitta Schlosser a,b, Giuseppina Cacace a,
Rosa Anna Siciliano a, Maria Fiorella Mazzeo a, Salvatore Scacco c, Tiziana Cocco c,
Antonio Gnoni c, Antonio Malorni a, Sergio Papa c,d
a Proteomic and Biomolecular Mass Spectrometry Centre, Institute of Food Science and Technology, CNR, via Roma 52, a/c, 83100 Avellino, Italy
b Research Group of Peptide Chemistry, Hungarian Academy of Sciences, Eötvös L. University, Budapest, Hungary
c Institute of Medical Biochemistry and Chemistry, University of Bari, Bari, Italy
d Institute of Biomembranes and Bioenergetics, Italian National Research Council, Bari, Italy
Received 13 February 2006; received in revised form 13 April 2006; accepted 24 May 2006
Available online 3 June 2006Abstract
Here we propose shotgun proteomics as an alternative method to gel-based bottom-up proteomic platform for the structural characterization of
mitochondrial NADH:ubiquinone oxidoreductase (complex I). The approach is based on simultaneous identification of subunits after global
digestion of the intact complex. Resulting mixture of tryptic peptides is purified, concentrated, separated and online analyzed using nano-scale
reverse-phase nano-ESI-MS/MS in a single information dependent acquisition mode. The usefulness of the method is demonstrated in our work on
the well described model system of complex I from bovine heart mitochondria. The shotgun method led to the identification and partial sequence
characterization of 42 subunits representing more than 95% coverage of the complex. In particular, almost all nuclear (except MLRQ) and 5
mitochondria DNA encoded subunits (except ND4L and ND6) were identified. Furthermore, it was possible to identify 30 co-purified proteins of
the inner mitochondrial membrane structurally not belonging to complex I. The method's efficiency is shown by comparing it to two classical 1 D
gel-based strategies. Shotgun proteomics is less laborious, significantly faster and requires less sample material with minimal treatment,
facilitating the screening for post-translational modifications and quantitative and qualitative differences of complex I subunits in genetic
disorders.
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NADH:ubiquinone oxidoreductase (complex I, EC 1.6.5.3)
is the largest in the number of subunits and molecular mass in
the family of protonmotive enzyme-complexes of the respira-
tory chain of mitochondria. This membrane-bound complex has
the most complicated structure and mechanism of action among
the mitochondrial electron transport/oxidative phosphorylation
system (OXPHOS) complexes [1]. Complex I from bovine
heart mitochondria is an excellent model system for both the
characterization of the corresponding human enzyme [2] and⁎ Corresponding author. Tel.: +39 0825299208; fax: +39 0825781585.
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doi:10.1016/j.bbabio.2006.05.037the study of hydrophobic multisubunit membrane-bound
protein complexes in general. Proteins of complex I assemble
into an L-shaped structure with the hydrophobic moiety
spanning the inner mitochondrial membrane and the catalytic
sector extending into the matrix [3]. Complex I of bovine heart
mitochondria consists of at least 46 subunits (Table 1), 7 of
which (ND1–ND6, and ND4L) are encoded by the mitochon-
drial DNA (mtDNA) [4–6].
Complex I deficiency is the most common and most severe
of oxidative phosphorylation defects. It can be caused by
alterations in both nuclear and mitochondrial encoded genes [7].
Impairment of complex I activity can be found in various
pathologies including neurodegenerative diseases like Hung-
tington's [8], Parkinson's [9,10] and Alzheimer's diseases [11]
Table 1
Mitochondrial NADH:ubiquinone oxidoreductase (complex I) subunits from bovine heart
Swiss-Prot access number Name of the gene Short name of the subunit Mwa Gravy score b Known PTMs c Number of cysteines
P15690 NUAM_BOVIN 75 kDa 77.0 kDa −0.124 – 17
P25708 NUBM_BOVIN 51 kDa 48.5 kDa −0.296 – 12
P17694 NUCM_BOVIN 49 kDa 49.2 kDa −0.337 – 6
P23709 NUGM_BOVIN 30 kDa 26.4 kDa −0.456 – 2
P04394 NUHM_BOVIN 24 kDa 23.8 kDa −0.294 – 5
P42026 NUKM_BOVIN 20 kDa 20.1 kDa −0.152 – 5
P42028 NUIM_BOVIN 23 kDa 20.2 kDa −0.487 – 8
P34942 NUDM_BOVIN 42 kDa 36.7 kDa −0.480 P-Ser59 d 5
P34943 NUEM_BOVIN 39 kDa 39.1 kDa −0.189 – 1
Q02375 NUYM_BOVIN 18 kDa 15.3 kDa −0.928 – 0
Q02379 NIPM_BOVIN 15 kDa 12.5 kDa −1.015 – 4
P23934 NUMM_BOVIN 13 kDa-A 10.5 kDa −0.671 – 3
P25712 NUOM_BOVIN 9 kDa 8.4 kDa −1.346 – 0
Q02374 NIGM_BOVIN AGGG 8.5 kDa −0.602 – 0
Q02372 NIAM_BOVIN ASHI 18.7 kDa −0.958 – 1
Q8HXG5 NESM_BOVIN ESSS 14.5 kDa −0.679 P-Ser20 e 1
Q02376 NIKM_BOVIN KFYI 5.8 kDa −0.465 – 0
Q01321 NUML_BOVIN MLRQ 9.3 kDa −0.433 – 0
Q02378 NINM_BOVIN MNLL 7.0 kDa −0.490 – 0
Q02377 NIMM_BOVIN MWFE 8.1 kDa −0.211 P-Ser55 e 1
Q02373 NIDM_BOVIN PDSW 20.8 kDa −0.989 – 5
P42029 NUPM_BOVIN 19k Da 20.0 kDa −0.717 – 8
P52505 ACPM_BOVIN 9.6 kDa 10.7 kDa −0.225 PPant-Ser44 1
Q02380 NISM_BOVIN SGDH 16.7 kDa −0.331 0
Q02369 NI2M_BOVIN B22 21.7 kDa −1.078 N-Ac f 4
Q02368 NB8M_BOVIN B18 16.5 kDa −1.003 N-Myr f 4
O97725 N7BM_BOVIN B17.2 17.1 kDa −0.804 N-Ac f 1
Q02367 NB7M_BOVIN B17 15.4 kDa −0.613 N-Ac f 0
Q95KV7 NB6M_BOVIN B16.6 16.6 kDa −0.322 N-Ac f 0
P48305 NB5M_BOVIN B15 15.1 kDa −0.688 N-Ac f 0
Q8HXG6 N5BM_BOVIN B14.7 14.7 kDa 0.245 N-Ac f 4
Q05752 N4AM_BOVIN B14.5a 12.6 kDa −0.700 N-Ac f 1
Q02827 N4BM_BOVIN B14.5b 14.1 kDa −0.350 N-Ac f 1
Q02366 NB4M_BOVIN B14 15.0 kDa −0.591 N-Ac f 0
P23935 NUFM_BOVIN 13 kDa-B 13.2 kDa −0.424 N-Ac f 1
Q02365 NB2M_BOVIN B12 11.1 kDa −0.692 N-Ac f 0
Q02371 NI9M_BOVIN B9 9.3 kDa −0.093 N-Ac f 0
Q02370 NI8M_BOVIN B8 11.0 kDa −0.372 N-Ac f 2
P03887 NU1M_BOVIN ND1 35.7 kDa 0.798 – 1
P03892 NU2M_BOVIN ND2 39.3 kDa 0.785 – 0
P03898 NU3M_BOVIN ND3 13.1 kDa 0.863 – 1
P03910 NU4M_BOVIN ND4 52.1 kDa 0.826 – 3
P03920 NU5M_BOVIN ND5 68.3 kDa 0.637 – 4
P03924 NU6M_BOVIN ND6 19.1 kDa 1.031 – 1
P03902 NU4LM_BOVIN ND4L 10.8 kDa 1.259 – 3
a Average molecular masses were calculated based on the amino acid sequences considering the known post-translational modifications (PTMs) using GPMAW5.11
software (Lighthouse Data, Odense, Denmark).
b GRAVY scores were calculated using Protalizer Version 0.1 software (http://microbio1.biologie.uni-greifswald.de/emaupt).
c Post-translational modifications: N-Ac=N-terminal acetylated, N-Myr=N-terminal myristylated, P=phosphorylation, PPant=modified by pantetheine 4′
phosphate.
d Schulenberg et al,. J. Biol. Chem. (2003) 278, 2725.
e Chen et al., J. Biol. Chem. (2004) 279, 26036.
f Carroll et al., Mol. Cell. Prot. (2005) 4, 693.
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[11] and cancer [14–17]. To date, diagnosis of OXPHOS
dysfunction is made by enzymatic and immunochemical
analysis of individual multiprotein complexes. Such analyses
require significant amounts of biopsy tissue or cell culture
material. To be able to associate specific gene alterations
(mutation, deletion, amplification) with structural modifications
at the protein level and/or impairment in the activity of complexI would be highly important in understanding the functional role
of complex I subunits. Furthermore, elucidation of the
genotype–phenotype correlation would help in clarifying the
pathogenic mechanism of a disorder long before symptoms
appear, with the possibility of effective timely therapy.
Improvements in mass spectrometry (MS) instrumentation
and methodology and the rapid growth of genomic databases
have allowed the development of high-throughput proteomic
1440 G. Pocsfalvi et al. / Biochimica et Biophysica Acta 1757 (2006) 1438–1450approaches used in identifying and quantifying a large number
of different proteins in cell organelles such as mitochondria.
Mitochondrial proteome maps of five different organisms have
been published [17–20] and are continuously updated. The
most widely applied proteomic strategy in the field of mito-
chondria and in the studies of the OXPHOS complexes is
bottom-up proteomics [21–24]. There are two basic strategies
in bottom-up proteomics. In gel-based methods the protein
mixture is separated prior to enzymatic cleavage. Protein iden-
tification is based on the peptide mass fingerprint of the protein
obtained by accurate mass measurement of the enzymatically
cleaved peptide fragments using MALDI-TOFMS or ESI-MS.
Alternatively, peptide sequencing can be carried out by means
of tandem MS/MS [24]. In the second approach (named
‘shotgun approach’) global digestion of the pool of proteins is
performed to produce a mixture of peptides which is then
separated and analyzed usually by multidimensional liquid
chromatography (LC) coupled to a tandem ESI mass
spectrometer. For the structural analysis of complex I gel-
based methodologies have been applied so far. Combination
of rigorous purification steps, different fractionation of the
intact complex into subcomplexes (ion-exchange, ammonium
sulfate precipitation and gel filtration), separation of subunits
(one-dimensional SDS-PAGE, two-dimensional isoelectrofo-
cusing/SDS-PAGE, and reverse-phase HPLC) and two
different MS-based protein identification methods (Peptide
mass fingerprinting (PMF) and MS/MS based sequencing)
allowed the identification of the known 46 subunits of
complex I [4] (Table 1). Blue-native polyacrylamide gel
electrophoresis (BN-PAGE) separation of the intact multi-
enzyme complexes is also extensively applied for
the characterization of mitochondrial OXPHOS complexes
[25]. BN-PAGE combined with a second SDS-PAGE
separation is used to generate two-dimensional map of the
individual subunits which subsequently can be identified by
MALDI-TOF PMF [25,26]. Recently, combination of BN-
PAGE with LC nano-ESI-MS/MS led to the identification of
32 complex I subunits out of 46 including some hydrophobic
components, except for the most problematic ND4L and ND6
subunits [27].
As a part of an effort to find more efficient analytical
methods, here we propose a novel shotgun proteomic platform
based on the simultaneous identification of subunits after global
digestion of the intact mitochondrial complex as an alternative,
and more efficient analytical method for the characterization of
membrane-bound complexes. The scope of this work was to
analyze the protein composition of a fully active preparation of
isolated complex I from bovine heart mitochondria using the
shotgun proteomic approach and to compare its performance to
the traditional gel-based techniques. Different digestion proto-
cols were tested in order to optimize experimental conditions for
the total digestion of the protein mixture using low amount of
starting material. Peptides were separated with reverse-phase
nano-HPLC and on-line analyzed by nano-ESI-MS/MS using
information dependent analysis (IDA) on a quadrupole time-of-
flight instrument (QTOF). The same sample was also analyzed
by traditional gel-based proteomic approaches combined byMALDI-TOFMS and HPLC-ESI-MS/MS analysis of the tryptic
peptides (Fig. 1).
2. Materials and methods
Protein molecular weight markers for SDS-PAGE analyses were from GE
Healthcare (Amersham Biosciences AB, SE-751 84 Uppsala, Sweden); 30%
Acrylamide/bis solution (37.5:1, 2.6%C), Coomassie Brilliant Blue G-250 were
from Bio-Rad (Hercules, CA, USA); sequencing grade, modified trypsin
(porcine) was from Promega (Madison, WI, USA). HPLC gradient grade
solvents (LichroSolv) were from Merck (Whitehouse Station, NJ, USA).
α-cyano-4-hydroxycinnamic acid was from Bruker Daltonics (Billerica, MA,
USA). RapiGest was from Waters (Milford, MA USA). ICAT kit was from
Applied Biosystems (Foster City, CA, USA).
Mitochondria were prepared from bovine heart as in [28]. Complex I was
isolated and purified by cholate solubilization and salts fractionation using the
standard procedure of Hatefi [29]. Concentration of flavin mononucleotide
(FMN) determined according to Ragan et al. [30] amounted to 0.8 nmol/mg.
Protein concentration of the sample was 47 mg/mL determined by Biuret assay
[31].
2.1. SDS-PAGE based proteomic identification of proteins
Complex I sample (2.2 μL,100 μg) was diluted in 5 μL buffer (0.125 M Tris
(hydroxymethyl) methylamine hydrochloride (Tris–HCl) pH 6.8, 4%, sodium
dodecyl sulfate (SDS), 20% Glycerol, 0.2 M dithiothreitol (DTT), 0.02%
bromophenol blue) containing 4 M Urea and 0.1% dodecylmaltoside solution
and boiled at 100 °C for 6 min. The sample was loaded on 12–22%
polyacrylamide gradient gel (16 cm×20 cm) according to the method of
Laemmli [32]. Electrophoresis was carried out using the Tris–glycine–SDS
buffer system (25 mM Tris, 192 mM glycine and 0.1% SDS) on a Protean II xi
cell apparatus (BioRad, Hercules, CA, USA) at 20 mA/gel until the dye front
reached the bottom edge of the gel. Low molecular weight standards were used
in the gel. Gel was fixed and stained with Coomassie Brilliant Blue G-250.
Selected gel bands were cut manually and placed into eppendorf tubes.
Reduction, alkylation and hydrolysis of proteins from gel bands were performed
according to Shevchenco [33] using 30 μL 10 mMDTT in 100 mMAmmonium
Bicarbonate (NH4HCO3), 30 μL 55 mM Iodoacetammide (IAA), in the same
buffer and 30 μL trypsin at 6 ng/μL concentration in 25 mM NH4HCO3.
2.1.1. MALDI-TOFMS analysis of gel separated proteins
0.5 μL of the tryptic peptide mixture was mixed with 0.5 μL of a saturated
solution of α-cyano-4-hydroxycinnaminic acid matrix (10 mg/mL in 50%
acetonitrile containing 25 fmol/μL angiotensin and 125 fmol/μL Adrenocortico-
tropic Hormone fragment 18–39 (ACTH) as internal standards). Themixturewas
spotted on aMALDI target plate and dried under ambient condition.Mass spectra
were generated on a MALDI-TOF mass spectrometer Voyager DE™ PRO
(Applied Biosystems, Foster City, CA, USA), operating in positive-ion reflectron
mode. The laser intensity (N2, 337 nm) was set just above the ion generation
threshold and pulsed every 10 ns. Mass spectra were acquired from each sample
in the 400–3500 m/z range, by accumulating 100 laser shots and were calibrated
using the monoisotopic peaks of angiotensin (m/z 931.5154) and ACTH (m/z
2465.1989) as internal standards. All mass values are reported as monoisotopic
masses. Protein identification was achieved by using the MALDI mass spectral
data for database search against the SwissProt database using the MASCOT
search algorithm (http://www.matrixscience.com). Parameters for database
search were as follows: mammalian as taxonomic category, trypsin as enzyme,
carbamidomethyl as fixed modification for cysteine residues and one missing
cleavage and 30 ppm as mass tolerance for the monoisotopic peptide masses.
2.1.2. Nano-HPLC ESI-MS and MS/MS analysis
Analysis of tryptic digest was performed on a QTOF Micro instrument
(Waters, Milford, MA, USA) equipped with a nanoflow electrospray ion source
employing coated silica capillaries (360 OD/100 ID, Tip 30 ID, New Objective,
Woburn, MA, USA) as nanoflow tip. Samples were loaded, purified and
concentrated on a pre-column PepMap, C18, 5 mm length, 300 Å, (LCPackings,
Sunnyvale, CA, USA) at 20 μL/min flow rate. Peptides were separated on a
Fig. 1. Flow chart of different mass spectrometry based proteomic approaches used for the identification of complex I subunits in this work.
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Sunnyvale, CA, USA), using a CapLC micro HPLC (Waters, Milford, MA,
USA). Flow rate was split from 5 μL/min to approximately 200 nL/min. Eluents:
(A) 2% acetonitrile in 0.1% formic acid (HCOOH) and B) 95% acetonitrile in
0.1% HCOOH were used. Separation was performed by a linear gradient: 2–
60% B in 30 min, 60–95% B in 2 min. Collision induced dissociation (CID) was
used to generate peptide fragments frommultiply charged molecular ions. Argon
was used as collision gas. Peak lists of survey experiments were generated by
ProteinLynx Global Server 2.1 (Waters, Milford, MA, USA) and used in
Mascot program (http://www.matrixscience.com) for database search. Search
criteria were as follows: species: mammals, type of search: MS/MS Ion Search,
enzyme: Trypsin, fixed modifications: Carbamidomethyl (C), variable mod-
ifications: Acetyl (N-term), Oxidation (M), Phosphorylation (S,T,Y); mass
values: monoisotopic, peptide mass tolerance: 100 ppm, fragment mass
tolerance: 0.1 Da and number of maximum missed cleavages: 2.
2.2. Analysis based on Shotgun proteomics
Three different protocols were used parallely for the enzymatic digestion of
complex I.
2.2.1. Protocol A
Sample (200 μg) was denatured using 36 μL of 50 mM Tris–HCl in 0.1%
SDS and reduced in boiling water for 10 min with 1 μL of Tris(2-carboxyethyl)
phosphine hydrochloride (TCEP). Alkylation was performed using 5 μL of
55 mM IAA in 50 mM NH4HCO3 for 30 min in dark at room temperature. The
reduced and alkylated sample was digested by trypsin (40 μL, 6 ng/μL in 25 mMNH4HCO3). After overnight incubation at 37 °C, the resulting peptide mixture
was acidified with 40 μL 0.1% TFA.
2.2.2. Protocol B
Complex I sample (200 μg) was dissolved in 20 μL 0.2% (w/v) RapiGest SF
solution. 5 μL 30 mM DTT in 50 mMNH4HCO3 was added and the solution was
incubated at 60 °C for 30 min. After boiling the sample for 5 min, 11 μL of 55mM
IAA in 50mMNH4HCO3 was added and the sample was placed in the dark for 30
min. Digestion and acidification were performed according to Protocol A.
2.2.3. Isotope-coded affinity tag (ICAT) labeling experiment
In another experiment isotope labeling was used in order to reduce sample
complexity by separating the mixture into two fractions: cysteine containing
peptides and cysteine non containing peptides, using ICAT labeling, cation
exchange and affinity chromatography [34]. 200 μg of sample was denatured and
reduced according to Protocol A. Alkylationwas performed using light chain ICAT
reagent (12C43H70N7O12Si) of the ICAT kit (Applied Biosystems, Foster City, CA,
USA). After the alkylation step, digestion was performed according to protocol A.
Peptides were purified by cation exchange chromatography and labeled peptides
were separated using avidin affinity column. Fractions were collected and analyzed
directly by nano-HPLC-ESI-MS/MS.
2.2.4. Nano-HPLC- ESI-MS/MS analysis of enzymatically digested complex I
sample
Nano-HPLC separation of peptide mixtures were performed using an
Integral 100Q HPLC system (PerSeptive Biosystems, Framingham, MA USA).
Flow rate was split from 400 μL/min to 200 nL/min using a flow splitter
1442 G. Pocsfalvi et al. / Biochimica et Biophysica Acta 1757 (2006) 1438–1450(Accurate, LCPackings, Sunnyvale, CA USA). Eluents: (A) 5% acetonitrile in
0.08% HCOOH and 0.01% TFA and (B) 95% acetonitrile in 0.08% HCOOH
and 0.01% TFA. Gradient: 5–50% B in 90 min 50–100% B in 5 min. 1 μg of
digested sample (about 1 pmol calculated for the pure complex I) was loaded,
purified and concentrated on a pre-column, PepMap, C18, 5 mm length, 300 Å
(LCPackings, Sunnyvale, CA, USA) using an external Phoenix HPLC pump
(Fisons-Instruments, Manchester, UK) at 20 μL/min flow rate. Peptides were
separated on a capillary column, C18 PepMap, 15 cm length, 75 μm ID, 300 Å
(LCPackings, Sunnyvale, CA, USA). For ESI-MS andMS/MS analysis a QTOF
type mass spectrometer (QStar-Pulsar, Applied Biosystems, Foster City, CA,
USA) equipped with a nanoflow electrospray ion source fitted with pulled
uncoated silica capillary (150 OD/50 ID) as nanoflow tip was employed.
Experiments were performed in IDA mode. Precursor ions were selected for
fragmentation using the following MS to MS/MS switch criteria: ions greater
than m/z 300.0, charge state 2 to 4, intensity exceeds 15 counts, former target
ions were excluded for 60 s, ion tolerance 50.0 mmu. CID was used to fragment
multiply charged ions. Nitrogen was used as collision gas. Automatically
generated peak lists were used for MS/MS ion search using the Mascot program
against the SwissProt database. The criteria for database searches were the ones
already used in the nano-HPLC-ESI-MS/MS experiments performed on the
QTOF-Micro instrument.Fig. 2. SDS-PAGE image of mitochondrial complex I from bovine heart. Gel
bands 1–31 visualized by Coomassie staining were excised and analyzed by
MALDI-TOFMS and nano-HPLC-ESI-MS/MS. Lane on the right shows the
molecular weight standards.3. Results
We performed analysis using traditional 1D gel-based
(MALDI PMF and ESI-MS/MS peptide sequencing) and
shotgun proteomic approaches (Fig. 1) to compare their
performances for the characterization of subunit composition
of a highly hydrophobic, multi-subunit protein complex. The
main difference between shotgun and gel-based approaches is
that in the first case subunits are not separated prior analysis but
directly digested by a proteolytic enzyme. This results in a very
complex mixture of peptides which is than separated and online
analyzed by ESI mass spectrometry using information depen-
dent MS and MS/MS analysis in an automated fashion.
Complex I was isolated from bovine heart mitochondria
using the standard procedure of Hatefi [29]. In this preparation
complex I retains its inhibitor sensitivity and enzymatic ac-
tivity [35]. The preparation is also known to have a relatively
high lipid content and can contain significant amounts of
transhydrogenase and other proteins related to the OXPHOS
system.
3.1. SDS-PAGE based proteomic method
The pattern of protein bands separated on SDS-polyacryla-
mide gradient gel (Fig. 2) shows similarities to those obtained
on a highly purified complex I sample by Carroll et al. [4].
Sample purity and differences in experimental conditions (such
as gel gradient), however, can influence the 1D gel pattern.
Thirty-one bands detected by Coomassie staining were excised
from the gel (Fig. 2) and the proteins present in each band were
digested with trypsin analyzed both by MALDI-TOFMS and by
nano-HPLC-ESI-MS/MS (Fig. 1). All bands except one (band 1)
contained more than one identified protein (Table 2 and Sup-
plementary Table 1).
3.1.1. Proteins identified by PMF
MALDI-TOFMS analysis of 31 gel bands led to the
identification of 37 mitochondrial proteins: twenty ninenuclear DNA encoded proteins from the complex I assembly
and eight subunits from other OXPHOS complexes. None of
the mtDNA encoded subunits nor subunits ESSS, B14.7,
B12, B9, KFYI, MLRQ, AGGG, MWFE and 9.6 kDa were
identified. It should be of note that all of the missing
subunits are hydrophobic, characterized by positive Gravy
scores (Table 1). Hydrophobic proteins entering into the gel
can result in diffused gel bands and poor staining with
Comassie blue dye. In addition their 1D gel-based analysis is
usually hampered by their low solubility. Some of the
subunits (such as 75 kDa, 51 kDa, 39 kDa, PDSW, B8)
were identified in more than one gel band, thus making 1D
gel-based image complicated. Co-migrating proteins due to
the low resolving power of electrophoresis is another
problem. For example, in band 19, four different subunits
(19 kDa, B22, B18 and PDSW) were identified simulta-
neously based on a single MALDI mass spectrum (Table 2).
Suppression effects, caused by co-migrated proteins, lower
protein scores and therefore limit the PMF-based protein
identification.
Eight proteins not directly belonging to complex I were
also identified in the sample by MALDI PMF. These include
succinate dehydrogenase flavoprotein (band 2) from complex
II; complex III core protein I (band 6) and cytocrome c1
(band 12); three subunits of cytocrome-c oxidase (complex
IV): IV (band 24), Va (band 27) and VIb (band 30); and two
ATP synthase (complex V) subunits: alpha (band 3) and beta
(bands 3, 4). Their presence can be explained by their co-
Table 2
Identified subunits and corresponding MASCOT scores obtained by 1D gel separation combined with MALDI-TOFMS PMF and nano-HPLC-ESI-MS/MS peptide sequencing
Band a Subunit b Swiss-Prot
access number
MALDI-TOFMS PMF ESI-MS/MS ion search
Score c Match d Coverage (%) e Score c Number of peptides sequenced Coverage (%) e
1 75 kDa P15690 331 32/52 50 1167 24 42
2 75 kDa P15690 294 30/46 45 600 19 28
49 kDa P17694 – – – 40 2 5
3 75 kDa P15690 107 18/96 28 278 6 12
51 kDa P25708 63 11/96 25 79 3 5
4 51 kDa P25708 113 13/53 31 227 8 17
75 kDa P15690 – – – 101 3 5
5 51 kDa P25708 159 12/20 30 545 13 28
6 51 kDa P25708 192 20/66 43 487 11 25
49 kDa P17697 173 18/66 40 357 8 18
75 kDa P15690 – – – 29 1 1
7 49 kDa P17694 174 14/33 41 595 12 31
51 kDa P25708 – – – 108 3 9
42 kDa P34942 – – – 32 2 7
75 kDa P15690 – – – 29 1 1
8 49 kDa P17694 156 17/68 38 205 7 18
42 kDa P34943 71 10/68 21 192 4 12
75 kDa P15690 59 11/68 17 53 2 3
51 kDa P25708 60 7/32 16 – – –
9 42 kDa P34942 156 14/42 44 399 8 26
49 kDa P17694 – – – 68 3 7
75 kDa P15690 – – – 53 2 6
10 39 kDa P34943 217 19/45 51 497 10 31
42 kDa P34942 – – – 15 1 2
11 39 kDa P34943 66 7/27 18 32 3 11
75 kDa P15690 64 8/27 10 – – –
12 39 kDa P34943 – – – 11 1 2
13 30 kDa P23709 219 17/40 58 307 7 28
14 24 kDa P04394 109 8/23 37 305 6 25
B22 Q02369 41 4/15 18 123 4 20
PDSW Q02373 – – – 51 3 20
23 kDa P42028 – – – 37 1 5
39 kDa P34943 – – – 18 2 5
15 24 kDa P04394 – – – 215 5 24
B22 Q02369 – – – 203 5 28
23 kDa P42028 – – – 202 4 22
PDSW Q02373 92 7/26 37 153 4 28
30 kDa P23709 – – – 64 2 9
49 kDa P17697 – – – 28 2 4
16 23 kDa P42028 52 5/27 27 244 4 22
PDSW Q02373 80 7/34 45 207 5 34
B22 Q02369 – – – 188 5 28
30 kDa P23709 – – – 117 3 13
24 kDa P04394 – – – 25 1 5
(continued on next page)
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Table 2 (continued)
Band a Subunit b Swiss-Prot
access number
MALDI-TOFMS PMF ESI-MS/MS ion search
Score c Match d Coverage (%) e Score c Number of peptides sequenced Coverage (%) e
17 PDSW Q02373 97 8/26 45 301 8 50
23 kDa P42028 74 6/18 21 220 6 27
B22 Q02369 – – – 227 5 28
30 kDa P23709 – – – 66 1 4
19 kDa P42029 – – – 62 2 14
24 kDa P04394 – – – 53 2 9
49 kDa P17697 – – – 42 2 4
20 kDa P42026 – – – 30 1 4
51 kDa P25708 – – – 20 1 2
18 PDSW Q02373 166 16/53 71 264 6 34
B22 Q02369 69 9/53 59 188 5 28
23 kDa P42028 68 7/28 28 113 3 14
20 kDa P42026 – 102 3 14
19 B22 Q02369 79 10/67 57 130 4 23
20 kDa P42026 – 121 3 14
PDSW Q02373 56 6/38 37 104 3 18
19 kDa P42029 80 12/67 52 49 1 6
B18 Q02368 70 7/45 41 39 2 19
23 kDa P42028 – – – 26 1 5
ASHI Q02372 – – – 11 2 10
20 B18 Q02368 92 9/64 64 167 5 36
19 kDa P42029 100 10/64 64 117 5 38
20 kDa P42026 48 5/38 15 104 3 14
ASHI Q02372 62 7/64 41 98 4 25
18 kDa Q02375 – 22 2 10
21 B18 Q02368 71 7/36 41 363 8 58
19 kDa P42029 53 5/29 31 140 5 27
18 kDa Q02375 – – – 126 3 16
20 kDa P42026 – – – 71 3 14
ASHI Q02372 – – – 19 2 10
22 18 kDa Q02372 75 9/62 41 225 4 22
B17 Q02367 55 6/44 35 158 4 27
B18 Q02368 57 6/38 34 136 3 28
ESSS Q8HXG5 – – – 54 2 14
19 kDa P42029 83 9/62 55 48 1 7
75 kDa P15690 – – – 28 1 1
20 kDa P42026 – – – 27 1 4
23 B17.2 O97725 82 6/24 46 239 8 55
SGDH Q02380 50 5/24 20 138 4 20
B16.6 Q95KV7 – – – 56 3 21
19 kDa P42029 – – – 29 1 6
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24 B17.2 O97725 158 12/44 66 336 6 64
B16.6 Q95KV7 52 5/26 25 275 6 48
B14.5b Q02827 – – – 41 1 9
SGDH Q02380 – – – 38 2 10
19 kDa P42029 – – – 32 1 6
25 B15 P48305 141 11/35 62 295 9 50
B14.5a Q05752 48 5/35 33 109 5 53
B14.5b Q02827 – – – 158 4 34
15 kDa Q02379 – – – 42 2 13
51 kDa P25708 – – – 32 3 6
B14 Q02366 – – – 18 1 6
26 B14 Q02366 – – – 106 4 14
B14.5b Q02827 47 4/26 35 83 3 23
B14.5a Q05752 91 9/42 58 57 2 13
15 kDa Q02379 73 7/42 57 57 2 13
B15 P48305 – – – 29 1 7
27 B12 Q02365 – – – 118 2 19
B14.7 Q8HXG6 – – – 71 1 7
B14 Q02366 52 6/43 35 45 2 18
13 kDa-A P23934 – – – 45 2 21
B22 Q02369 – – – 35 1 7
13 kDa-B P23935 59 6/49 40 27 1 13
B14.5b Q02827 – – – 18 1 9
23 kDa P42028 – – – 17 1 5
28 13 kDa-A P23934 74 6/36 54 275 6 41
13 kDa-B P23935 81 7/36 44 138 4 31
B8 Q02370 – – – 112 3 33
B12 Q02365 – – – 107 2 37
B22 Q02369 – – – 26 1 7
30 kDa P23709 – – – 24 1 4
B14.5b Q02827 – – – 20 1 6
B16.6 Q95KV7 – – – 20 1 6
29 B8 Q02370 138 11/38 75 222 4 37
B14.7 Q8HXG6 – – – 29 1 7
9 kDa P25712 63 6/27 39 – – –
30 MNLL Q02378 – – 46 1 14
B8 Q02370 58 5/25 45 – – –
31 MNLL Q02378 45 3/16 33 – – –
B9 Q02371 – – – 37 1 8
a Number of SDS-PAGE gel bands as shown in Fig. 2.
b Short name of the identified complex I subunits ( as in Table 1). Other OXPHOS proteins identified by SDS-PAGE MALDI PMF and/or HPLC-ESI-MS/MS sequencing are listed in the text and in Supplementary
Table 1.
c MASCOT score of PMF and MS/MS ion searches, respectively.
d Matched peaks/total number of peaks sent to MASCOT PMF search.
e Protein sequence coverage in percentage obtained by PMF and MS/MS identifications, respectively.
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Table 3
Identified proteins and their respective MASCOT scores obtained by the shotgun approach using protocol A, protocol B and ICAT labeling experiment
Subunit Swiss-Prot
access
number
Protocol A Protocol B ICAT labeling experiment
Score Number of peptides
sequenced
Score Number of peptides
sequenced
Score Number of
peptides
sequenced
75 kDa P15690 1412 31 859 24 992 24
51 kDa P25708 1075 23 403 11 378 13
49 kDa P17694 501 13 285 9 300 8
30 kDa P23709 568 10 402 7 656 10
24 kDa P04394 549 12 332 10 295 7
20 kDa P42026 118 3 51 1 88 3
23 kDa P42028 178 5 104 2 201 4
42 kDa P34942 314 7 264 6 319 8
39 kDa P34943 594 12 464 12 377 10
18 kDa Q02375 270 7 183 5 108 3
15 kDa Q02379 200 5 87 2 76 2
13 kDa-A P23934 468 8 87 4 168 3
9 kDa P25712 122 3 32 4 n.d. –
AGGG Q02374 26 1 28 1 n.d. –
ASHI Q02372 269 7 106 5 33 2
ESSS Q8HXG5 178 5 61 2 77 4
KFYI Q02376 n.d. – 26 1 n.d. –
MLRQ Q01321 n.d. – n.d. – n.d. –
MNLL Q02378 42 1 13 2 9 1
MWFE Q02377 21 1 7 2 25 1
PDSW Q02373 499 11 350 11 229 6
19 kDa P42029 387 9 248 6 280 9
9.6 kDa P52505 330 8 206 6 263 8
SGDH Q02380 164 4 26 2 90 2
B22 Q02369 329 8 160 5 146 4
B18 Q02368 236 6 127 4 360 8
B17.2 O97725 301 7 221 5 189 4
B17 Q02367 177 5 80 4 50 2
B16.6 Q95KV7 316 11 125 5 100 3
B15 P48305 234 5 126 5 70 3
B14.7 Q8HXG6 152 3 118 2 142 3
B14.5a Q05752 355 9 155 4 81 2
B14.5b Q02827 127 2 123 2 125 2
B14 Q02366 182 3 96 4 81 3
13 kDa-B P23935 169 4 216 6 219 5
B12 Q02365 90 2 72 1 n.d. –
B9 Q02371 42 2 35 1 n.d. –
B8 Q02370 207 4 268 9 116 2
ND1 P03887 n.d. – 109 3 113 2
ND2 P03892 n.d. – 21 1 32 1
ND3 P03898 n.d. – n.d. – 27 1
ND4 P03910 23 2 47 1 32 2
ND4L P03902 n.d. – n.d. – n.d. –
ND5 P03920 90 4 237 7 77 2
ND6 P03924 n.d. – n.d. – n.d. –
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excluded that they play a role in the assembly or regulation
of complex I.
3.1.2. Proteins identified by peptide sequencing
In this experiment peptide mixtures from in-gel tryptic
digestion of the 31 SDS-PAGE bands (Fig. 2) were fractionated
by reverse-phase nano-HPLC and the proteins were analyzed by
nano-ESI-MS/MS in data dependent acquisition (DDA) mode
(Fig. 1). In total, 50 proteins including thirty two complex I
subunits out of 46 were identified (Table 2 and SupplementaryTable 1). The presence of four subunits, ESSS (band 22), B14.7
(bands 27 and 29), B12 (bands 27 and 28) and B9 (band 31), not
identified by MALDI PMF, was also confirmed. However, the
seven mtDNA encoded subunits ND1–ND6 and ND4L, were
not detected, nor were subunits 9 kDa (8437.4 Da), AGGG
(8.493.4 Da), KFYI (5828.7 Da), MLRQ (9324.7 Da), MWFE
(8105.4 Da), and 9.6 kDa (10109.7 Da). It should be noted that
all of the missing nuclear encoded subunits have low-molecular
masses and thus they migrate in a congested, high polyacryla-
mide percentage region of the gel (below 10 kDa) where their
extraction and consequently their detection is difficult. In
1447G. Pocsfalvi et al. / Biochimica et Biophysica Acta 1757 (2006) 1438–1450addition, they generally produce only a few proteolytic
fragments upon tryptic digestion, thus limiting protein identifi-
cation by MS.
With this approach generally more proteins were identified
in a single gel band compared to the PMF-based method
(Table 2) because the limited resolving power of SDS-PAGE
was compensated by the HPLC separation of the peptides.
HPLC-ESI-MS/MS experiments showed the presence of 18
proteins in the sample which do not belong to complex I
(Supplementary Table 1): three subunits from Ubiquinol—
cytochrome-c reductase complex (complex III): Core protein I
(bands 5–6) and II (band 7) and iron–sulfur subunit (band 15);
four subunits from Cytochrome c oxidase (complex IV)
polypeptides: IV isoform 1 (band 24), Va (band 27), Vb
(band 27) and VIb (band 29); and eight ATP synthase
(complex V) chains: alpha (band 3), beta (bands 3–5) chain B
(band 14), oligomycin sensitivity conferral protein (bands 16–
17), chain D (bands 16–17), e chain (bands 27–28), f chain
(bands 28–29) and delta chain (band 25) and three other
mitochondrial proteins like Acetyl-CoA carboxylase 1 (band
7), NAD(P) transhydrogenase (band 17) and ADP, ATP carrier
protein, heart isoform T1 (band 16) were identified.Table 4
Proteins non belonging to complex I identified by the shotgun approach using Proto
Name of the protein Protocol A
Score Numb
seque
Complex
V
ATP synthase alpha chain heart isoform 507 12
ATP synthase beta chain 613 17
ATP synthase gamma chain 27 1
ATP synthase delta chain 36 1
ATP synthase B chain 27 1
ATP synthase D chain 26 1
ATP synthase E chain n.d. –
ATP synthase F chain 37 1
ATP synthase 8 (subunit 8) n.d. –
ATP synthase oligomycin sensitivity conferral protein n.d. 1
Complex
III
Ubiquinol–cytochrome-c reductase complex
core protein 1
87 2
Ubiquinol–cytochrome-c reductase complex
core protein 2
113 3
Ubiquinol–cytochrome c reductase iron–sulfur
subunit
13 1
Ubiquinol–cytochrome c reductase complex
11 kDa protein
59 1
Ubiquinol–cytochrome c reductase complex
14 kDa protein
n.d. –
Cytochrome c1, haem protein 17 1
Complex
II
Succinate dehydrogenase [ubiquinone]
flavoprotein subunit
8 1
Complex
IV
Cytochrome c oxidase polypeptide II 14 1
Cytochrome c oxidase subunit IV isoform 1 93 4
Cytochrome c oxidase polypeptide Va 101 2
Cytochrome c oxidase polypeptide VIa-heart 34 2
Cytochrome c oxidase polypeptideVIIa-heart 38 1
Cytochrome c oxidase polypeptide Vb 78 2
Cytochrome c oxidase polypeptide VIb 36 1
Other Translation initiation factor IF-2 33 2
ADP,ATP carrier protein, heart isoform T1 121 5
ADP, ATP carrier protein n.d. –
NAD(P) transhydrogenase 909 243.2. Subunits identified by shotgun proteomic approach
Samples obtained by total tryptic digestion of complex I
were analyzed by nano-HPLC-ESI-MS/MS in IDA mode. Two
protocols (Protocols A and B) differing in denaturation and
reducing conditions were tested to compare their efficiency in
the identification of subunits, especially the most hydrophobic
ones. These results are summarized in Table 3 (Supplementary
Table 2 and 3). The results show generally higher MASCOT
scores, reflecting a better sequence coverage per single subunit
by protocol A. Based on the number of identified proteins,
however, the performance of protocol B (RapiGest as denatur-
ing buffer and DTT as reducing agent) (Supplementary Table 3)
was slightly better than Protocol A (50 mM Tris–HCl in 0.1%
SDS and TCEP) (Supplementary Table 2). Protocols A and B
yielded the identification of 38 and 41 subunits, respectively. In
the latest experiment, almost all nuclear encoded subunits
(except MLRQ) plus four of the seven mitochondrial subunits
(except ND3, ND4L and ND6) were detected.
In another experiment, after denaturation and reduction
(which was performed according to protocol A) stabile isotope
labeling of cysteine residues was carried out using acid-labilecol A, Protocol B and ICAT labeling experiments, respectively
Protocol B ICAT labeling experiment
er of peptides
nced
Score Number of peptides
sequenced
Score Number of peptides
sequenced
629 13 370 9
197 6 369 10
27 1 n.d. –
n.d. – n.d. –
27 1 n.d. –
71 2 87 3
31 1 n.d. –
39 1 63 1
27 1 19 2
48 2 61 1
48 1 142 4
43 1 72 2
n.d. – n.d. –
14 1 37 1
19 1 37 1
36 1 55 2
71 1 52 1
35 1 n.d. –
41 2 11 1
46 1 37 1
20 1 n.d. –
25 2 42 1
135 3 n.d. –
26 1 47 2
13 1 n.d. –
48 1 51 2
48 1 99 3
426 15 313 16
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Biosystems, Inc., www.appliedbiosystems.com) [34]. The
scope of this analysis was to reduce sample complexity by
separating the peptides into two fractions (peptides having
cysteine residues and peptides without cysteines) (Table 1) in
order to improve identification of subunits. After labeling, the
peptides were separated by affinity capture of the biotin tag on
immobilized avidin column. The flow-through and the binding
fractions were analyzed by nano-HPLC-ESI-MS/MS in IDA
mode. Scores of the individual subunits were calculated as a sum
of the two analyses (Table 3 and Supplementary Table 4). The
results show that ICAT labeling and separation was the most
efficient in the identification of mitochondrial encoded subunits,
identifying five of these (ND1–ND4 and ND5), however, some
of the nuclear encoded subunits already identified by protocol B
(10 kDa, AGGG, B9, KFYI and B12) (Table 3, Supplementary
Table 3) could not be detected in this way. This shows that the
complexity of the sample still hampers the successful identifica-
tion of some of the highly hydrophobic nuclear encoded
subunits.
It should be noted that identification of KFYI, MLRQ,
ND4L and ND6 subunits is the most problematic. KFYI protein
was identified only by protocol B (Table 3). MLRQ is 9 kDa
protein whose presence in the complex is not certain. It was not
detected in any of the reported experiments. The absence of
ND4L and ND6 identification is due to the low number of
theoretical cleavage sites: using tryptic digestion, only a few
peptides can be generated in the high molecular mass region,
making difficult subsequent MS analyses. The smallest peptides
obtained from the theoretical enzymatic cleavage of ND6 and
ND4L have, in fact, molecular masses of 2510.33 Da and
2700.30 Da, respectively. MS/MS sequencing of such high
molecular weight peptides raise problems. ND4L also has the
highest Gravy score (1.259) and the lowest molecular mass
amongst the mitochondrial encoded highly hydrophobic
proteins (Table 1).
In several nuclear subunits of complex I the N-terminal
methionine has been removed post-translationally; in other
nuclear subunits the mitochondrial import sequence has been
removed [36]. Fourteen of the nuclear encoded complex ITable 5
Summary of the identified complex I subunits using different proteomic approaches
Strategy Identification method Nuclear encoded subunits
1D gel-based MALDI-TOFMS PMF 75 kDa, 51 kDa, 49 kDa, 30 kDa, 24 kD
15 kDa, 13-AkDA, 9 kDa, ASHI, MNL
B17, B16.6, B15, B14.5a, B14.5b, B14
HPLC-ESI-MS/MS
sequencing
75 kDa, 51 kDa, 49 kDa, 30 kDa, 24 kD
15 kDa, 13 kDa-A, ASHI, ESSS, MNL
B17, B16.6, B15, B14.7, B14.5a, B14.5
Shotgun HPLC-ESI-
MS/MS
sequencing
75 kDa, 51 kDa, 49 kDa, 30 kDa, 24 kD
15 kDa, 13 kDa-A, 9 kDa, AGGG, ASH
19 kDa, 9.6 kDa, SGDH, B22, B18, B1
B14.5b, B14, 13 kDa-B, B12, B9, B8subunits are known to have modified N-terminals (Table 1)
[37]. We have found that five of these subunits (B22, B17.2, B8,
13 kDa-A and B16.6) are N-α-acetylated (Supplementary
material, Table 2). Complex I from bovine heart has different
potentially phosphorylated subunits including the 42 kDa (Ser-
59) [38], ESSS (Ser-20) [39], MWFE (Ser-55) [39] and the
18 kDa (position 129–131) [40] subunits (Table 1). Our MS/MS
experiments, however, did not confirm any steady-state phos-
phorylation of complex I subunits, probably due to their low
degree of modification.
3.2.1. Other proteins identified by the shotgun proteomic
approach
Using the shotgun approach, 30 co-purified proteins in-
volved in the electron transport chain, but structurally not
directly linked to complex I, were also identified (Table 4). The
highest number of proteins were identified by Protocol B.
Majority of these proteins belongs to the OXPHOS system:
11 proteins related to complex V subunit, 8 subunits of com-
plex IV, 6 of complex III and 1 complex II subunit were
identified. They can be co-purified proteins, or alternatively,
proteins involved in the successful assembly and regulation of
the complex.
4. Discussion
Given the importance of complex I impairment in a large
number of pathologies, advanced genomic and proteomic tools
have recently been employed to identify mutations and struc-
tural and functional alterations of constituent subunits and
assembly factors of the complex specifically associated with the
various diseases. Today, proteomic approaches based on gel
electrophoresis combined with mass spectrometry are the pre-
ferred techniques for the characterization of the complex I
[4,6,27]. In spite of the success of classical gel-based pro-
teomics for determining the subunit composition of complex I,
the approach has its limitations with regard to membrane
proteins [41]. In addition these approaches require a relatively
large quantity of samples (100 μg), laborious purification pro-
cedures and time-consuming analytical steps with the risk ofMitochondrial
encoded
subunits
Number of
identified
subunits
a, 20 kDa, 23 kDa, 42 kDa, 39 kDa, 18 kDa,
L, PDSW, 19 kDa, SGDH, B22, B18, B17.2,
, 13 kDa-B, B8
None 29
a, 20 kDa, 23 kDa, 42 kDa, 39 kDa, 18 kDa,
L, PDSW, 19 kDa, SGDH, B22, B18, B17.2,
b, B14, 13kDa-B, B12, B9, B8
None 32
a, 20 kDa, 23 kDa, 42 kDa, 39 kDa, 18 kDa,
I, ESSS, KFYI, MNLL, MWFE, PDSW,
7.2, B17, B16.6, B15, B14.7, B14.5a,
ND1 42
ND2
ND3
ND4
ND5
1449G. Pocsfalvi et al. / Biochimica et Biophysica Acta 1757 (2006) 1438–1450sample loss and sample alteration, therefore they cannot be
applied in clinical screen testing.
In this work, we applied the shotgun proteomic approach
for the identification of the proteins present in less than 1 μg
enzymatically active complex I isolated from bovine heart.
Table 5 shows the identified subunits obtained by three
different proteomic strategies. The shotgun approach led to
the identification of 42 subunits (corresponding to more than
95% of all complex I subunits) while 29 and 32 subunits
were identified by the two SDS-PAGE based bottom-up
strategies: MALDI-TOFMS PMF, and nano-HPLC-ESI-MS/
MS sequencing, respectively. In particular, IDA experiments
allowed the identification of five mtDNA (except ND4L and
ND6) and almost all nuclear encoded subunits (except
MLRQ), therefore demonstrating the superior performance of
the shotgun approach compared to gel-based methods in the
characterization of mitochondrial complexes.
Gathering all our data, we were able to identify 70 different
mitochondrial proteins with the shotgun proteomic approach
compared to 37 and 50 proteins identified with gel-based
methods (MALDI-TOFMS and HPLC-ESI-MS/MS, respec-
tively). This clearly shows that shotgun proteomics gave a
better overall performance in the identification of the proteins
present in a highly complex mixture. Some of these proteins
structurally are not linked to complex I. These can be co-
purified proteins, and their presence depend on the protocol
used for the isolation of complex I. At the same time we
cannot exclude the hypothesis that they have biochemical role
in the assembly, stabilization, regulation and substrate
channeling of complex I through the formation of supramo-
lecular complexes. The association of the mitochondrial
respiratory chain complexes into higher supramolecular
structures called supercomplexes has been shown by isolation
of structural associates using BN-PAGE [42]. Supercomplexes
containing complexes I, III and IV have been isolated from
bovine heart mitochondria. It has also been demonstrated that
assembled complex III is required to stabilize the structure of
complex I in mammalian cells [43] and the early stage of
complex I assembly is linked to complex III and IV
supercomplexes [44]. It should be noted that subunits from
other OXPHOS complexes have been also found in a BN-
PAGE separated complex I sample [27].
With the shotgun approach discussed herein, the time of the
analysis was reduced considerably compared to gel based
approaches. Nano-HPLC-ESI-MS/MS analysis of peptides
generated from the digestion of the intact complex needs only
a few hours, rendering it quite advantageous for clinical
screening. The method can also be useful to probe post-
translational modifications as it was proved by the identification
of N-acetylation of some of the subunits. ICAT labeling also
gives the opportunity to quantify changes in protein abundance
[45]. In this manner, shotgun proteomics combined with isotope
labeling can become a useful tool for relative quantification of
samples, and also for the screening of post-translational
modification. In addition, the shotgun approach could be useful
for the analysis in human patients of defects in complex I
assembly and characterization of sub-complexes [46,47]. Sinceincreased complexity of the peptide mixture can be difficult to
handle with one dimensional RP-HPLC separation, the method
can be further improved by higher resolution chromatographic
separation procedures like multidimensional HPLC.
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